Data in GSE13507 verified that CDCA3 was elevated in bladder urothelial carcinoma tissues (Fig. 1e) and demonstrated that patients with shorter survival span tended to present a higher CDCA3 level (Fig. 1f) which showed that CDCA3 was also a potential predictor of bladder urothelial carcinoma. The gene discussed is CDCA3; the disease is bladder transitional cell carcinoma.